Why Is Thermo Fisher ( TMO ) Up 0.2% Since Last Earnings Report?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates
VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
LH Shares Gain Following Publication of New Plasma Detect MRD Data
Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.
Why Is Intuitive Surgical ( ISRG ) Up 7.1% Since Last Earnings Report?
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical, Inc. ( ISRG ) Recently Broke Out Above the 20-Day Moving Average
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Reasons to Add HealthEquity Stock to Your Portfolio for Now
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.
If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner
Thermo Fisher's new all-in-one SureTect qPCR assay promises faster, broader beverage spoilage detection and sharper quality control.
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial
WMT gains on omnichannel strength and rising e-commerce momentum, though tariffs and expense pressures temper the retailer's outlook.
Where Will Intuitive Surgical Stock Be in 10 Years?
Intuitive Surgical's business starts with the sale of a da Vinci surgical robot, but that's not where it ends.
EXPLORING THE GLOBAL TRANSFORMATION OF HEALTH CARE WITH ELI LILLY's CEO DAVE RICKS - T. Rowe Price Group ( NASDAQ:TROW )
Newest episode of "The Angle" from T. Rowe Price out now BALTIMORE, Nov. 19, 2025 /PRNewswire/ -- T.
Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
10 Years Later: 5 Lesser-Known Rule Breakers
We're back with the second episode of a new series -- 10 Years Later -- where we blast through time to check in on a five-stock sampler from 10 years in the past.
BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs
Butterfly Network unveils Compass AI to streamline POCUS workflows, boosting documentation compliance and unlocking more revenue for health systems.
Intuitive Surgical, Inc. ( ISRG ) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Ecolab Launches Integrated Cooling Platform to Support AI Data Centers
ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run.
Intuitive Surgical just went through a big drawdown, but if history is any guide, that will open up the next bull run for the stock.
3 Unstoppable Growth Stocks to Buy Right Now
The market just handed patient investors a gift -- three high-growth companies solving real problems, now trading at 30-day lows.
9 Robotics Stocks to Buy Before the Automation Wave Peaks
Labor shortages and the rise of AI are converging to make the adoption of robotics increasingly inevitable.
Here's How Much $1000 Invested In Intuitive Surgical 5 Years Ago Would Be Worth Today - Intuitive Surgical ( NASDAQ:ISRG )
Intuitive Surgical ( NASDAQ:ISRG ) has outperformed the market over the past 5 years by 4.17% on an annualized basis producing an average annual return of 17.5%. Currently, Intuitive Surgical has a market capitalization of $198.29 billion.
Is It Time to Dump Your Shares of Intuitive Surgical?
Intuitive Surgical's shares have risen more than 30% in a month, but whether or not you sell now depends on why you bought it.
HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience
HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.
Top Robotics Stocks to Add to Your Portfolio for Impressive Returns
Robotics is poised for robust long-term growth. Consider NVDA, TRMD and TER for potential market dominance across sectors.
Is Force Feedback the Next Big Catalyst for ISRG's da Vinci Sales?
Intuitive Surgical's new force-feedback upgrades for da Vinci 5 could spark its next adoption wave as early clinical evidence strengthens.
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.
2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon
If you're a new investor looking for some long-term opportunities, don't overlook these top healthcare buys.
Izzy Englander and Cathie Wood Agree: This Growth Stock Is a Buy
This might be a good time to play follow-the-leader.
Intuitive Surgical's Options Frenzy: What You Need to Know - Intuitive Surgical ( NASDAQ:ISRG )
Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical. Looking at options history for Intuitive Surgical ( NASDAQ:ISRG ) we detected 13 trades.
Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
Medtronic has its own surgical robot and it is working to become a more profitable business.
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.
Is the Market Bullish or Bearish on Intuitive Surgical Inc? - Intuitive Surgical ( NASDAQ:ISRG )
Intuitive Surgical Inc's ( NYSE:ISRG ) short interest as a percent of float has fallen 9.13% since its last report. According to exchange reported data, there are now 7.39 million shares sold short, which is 2.09% of all regular shares that are available for trading.
ISRG Stock Gains More than 28% in a Month: Should You Buy, Hold or Sell?
Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.
Investors Heavily Search Intuitive Surgical, Inc. ( ISRG ) : Here is What You Need to Know
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
ALC or ISRG: Which Is the Better Value Stock Right Now?
ALC vs. ISRG: Which Stock Is the Better Value Option?
Will These 2 Robotics ETFs Surge 50% or More as the AI Revolution Takes Off?
Robotics is an interesting opportunity, but choosing individual stocks isn't for everyone.
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
How Intuitive Surgical Stock Gained 19.5% Last Month
Intuitive Surgical crushed earnings expectations in October, and the stock soared. Is this high-flying robotic surgery leader still worth buying at these prices?
$1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today - Intuitive Surgical ( NASDAQ:ISRG )
Intuitive Surgical ( NASDAQ:ISRG ) has outperformed the market over the past 20 years by 12.63% on an annualized basis producing an average annual return of 21.57%. Currently, Intuitive Surgical has a market capitalization of $192.98 billion.
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon
The healthcare industry is chock-full of opportunities for long-term investors.
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
If you are an aggressive investor who thinks in decades, this trio of growth stocks comes with high risks but could offer huge rewards.
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.
BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
Prediction: These 2 Magnificent S&P 500 Growth Stocks Will Crush the Market Over the Next 5 Years
Both of these companies are proven winners with continued long-term potential ahead.
Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand
RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.
Abner Herrman & Brock Sours on Intuitive Surgical
Abner Herrman & Brock LLC ( AHB ) reduced its stake in Intuitive Surgical ( NASDAQ:ISRG ) by almost 10,000 shares, worth over $4.5 million, during the quarter ended September 30, 2025.According to its October 14, 2025 SEC filing, Abner Herrman & Brock trimmed its position in Intuitive Surgical ( ...
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
BIO's Q3 earnings fall short of estimates despite higher revenues, as margin pressure and weak research demand weigh on results.
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
